Sharman John Stewart 4
4 · UNIVERSAL BIOSENSORS INC · Filed Mar 25, 2024
Insider Transaction Report
Form 4
Sharman John Stewart
Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-25$0.20/sh+1,364,666$272,933→ 1,444,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-25−1,364,666→ 0 totalExercise: $0.20Exp: 2024-03-24→ Common Stock (1,364,666 underlying)
Holdings
- 2,364,667
Stock Option (Right to Buy)
Exercise: $0.25Exp: 2025-03-24→ Common Stock (2,364,667 underlying) - 1,250,000
Perforamnce Rights
Exp: 2025-03-24→ Common Stock (1,250,000 underlying) - 276,217(indirect: By Spouse)
Common Stock
- 1,364,667
Stock Option (Right to Buy)
Exercise: $0.30Exp: 2025-03-24→ Common Stock (1,364,667 underlying) - 2,500,000
Performance Rights
Exp: 2025-03-24→ Common Stock (2,500,000 underlying) - 1,000,000(indirect: By superannuation fund)
Stock Option (Right to Buy)
Exercise: $0.30Exp: 2025-03-24→ Common Stock (1,000,000 underlying)
Footnotes (5)
- [F1]The reporting person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
- [F2]The price reported is stated in Australian dollars.
- [F3]The options are fully vested and became exercisable after September 24, 2020. The options expiring in March 2024 were exercised on March 25, 2024.
- [F4]Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
- [F5]Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.